Compare AGNC Investment Corp (AGNC) vs Cronos Group Inc (CRON) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AGNC Investment Corp vs Cronos Group Inc — how do they compare? AGNC Investment Corp trades at $10.9 (market cap $12.91B), while Cronos Group Inc trades at $3.08 (market cap $1.14B). The key difference: AGNC Investment Corp is far larger — about 11.3× Cronos Group Inc's market cap, and AGNC Investment Corp pays a 13.22% dividend while Cronos Group Inc pays none. Which is the better fit depends on your goals.
| AGNC | CRON | |
|---|---|---|
Market Cap | $12.91B | $1.14B |
Sector | Financials | Health |
52-Week High | $12.17 | $3.27 |
52-Week Low | $9.46 | $2.30 |
Dividend Yield | 13.22% | — |
Enterprise Value | — | $341.13M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About AGNC Investment Corp
AGNC Investment Corp is a real estate investment trust that invests in agency residential mortgage-backed securities. The firm's asset portfolio is comprised of residential mortgage pass-through securities and collateralized mortgage obligations for which the principal and interest payments are guaranteed by a U.S. Government-sponsored enterprise, such as the Federal National Mortgage Association and the Federal Home Loan Mortgage Corporation, or by a U.S. Government agency, such as the Government National Mortgage Association. It also invests in other types of mortgage and mortgage-related residential and commercial mortgage-backed securities or other investments in or related to, the housing, mortgage or real estate markets.
Read more on AGNC →About Cronos Group Inc
Cronos Group, headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis to Poland and Germany. In addition, it has entered joint ventures in Israel, Colombia, and Australia to drive further international cultivation and distribution growth. In the U.S. the company directly sells hemp-derived CBD and has an option to acquire 10.5% of U.S. multistate operator PharmaCann.
Read more on CRON →
